Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: An in vivo toxicity assay
Liang H., Baudouin C., Faure M.-O., Lambert G., Brignole-Baudouin F.
View publication
-
Therapeutic Area
Glaucoma
-
Technology
Pharmacology
-
Categories
Preclinical development
-
Affiliations
Paris Descartes University, Faculty of Biological and Pharmacological Sciences, Department of Toxicology, Paris, France; INSERM, Institut de la Vision, Department of Therapeutics, 17 rue Moreau, 75012 Paris, France; UPMC University Paris, Institut de la Vision, Paris, France; Quinze-Vingts National Hospital of Ophtalmology, Department of Ophthalmology, Paris, France; Quinze-Vingts National Hospital of Ophtalmology, Department of Biology, Paris, France; Ambroise Paré Hospital, APHP, Versailles Saint-Quentin en Yvelines University, Paris, France; Novagali Pharma SA, Evry, France